Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
Clinical trial NCT00140075 · COMPLETED
Trial details
- NCT number
- NCT00140075
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
- Primary completion
- 2006-08-01
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.